HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

TFPI-2 silencing increases tumour progression and promotes metalloproteinase 1 and 3 induction through tumour-stromal cell interactions.

Abstract
Tissue factor pathway inhibitor-2 (TFPI-2) is a potent inhibitor of plasmin which activates matrix metalloproteinases (MMPs) involved in degradation of the extracellular matrix. Its secretion in the tumour microenvironment makes TFPI-2 a potential inhibitor of tumour invasion and metastasis. As demonstrated in aggressive cancers, TFPI-2 is frequently down-regulated in cancer cells, but the mechanisms involved in the inhibition of tumour progression remained unclear. We showed in this study that stable TFPI-2 down-regulation in the National Cancer Institute (NCI)-H460 non-small cell lung cancer cell line using specific micro interfering micro-interfering RNA promoted tumour progression in a nude mice orthotopic model that resulted in an increase in cell invasion. Moreover, TFPI-2 down-regulation enhanced cell adhesion to collagen IV and laminin via an increase in α(1) integrin on cell surface, and increased MMP expression (mainly MMP-1 and -3) contributing to cancer cell invasion through basement membrane components. This study also reveals for the first time that pulmonary fibroblasts incubated with conditioned media from TFPI-2 silencing cancer cells exhibited increased expression of MMPs, particularly MMP-1, -3 and -7, that are likely involved in lung cancer cell invasion through the surrounding stromal tissue, thus enhancing formation of metastases.
AuthorsGuillaume Gaud, Sophie Iochmann, Audrey Guillon-Munos, Benjamin Brillet, Stéphanie Petiot, Florian Seigneuret, Antoine Touzé, Nathalie Heuzé-Vourc'h, Yves Courty, Stéphanie Lerondel, Yves Gruel, Pascale Reverdiau
JournalJournal of cellular and molecular medicine (J Cell Mol Med) Vol. 15 Issue 2 Pg. 196-208 (Feb 2011) ISSN: 1582-4934 [Electronic] England
PMID20015200 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2011 The Authors Journal of Cellular and Molecular Medicine © 2011 Foundation for Cellular and Molecular Medicine/Blackwell Publishing Ltd.
Chemical References
  • Collagen Type IV
  • Glycoproteins
  • Integrin alpha1
  • Laminin
  • tissue-factor-pathway inhibitor 2
  • Matrix Metalloproteinases
Topics
  • Animals
  • Carcinoma, Non-Small-Cell Lung (genetics, pathology, physiopathology)
  • Cell Adhesion
  • Cell Line, Tumor
  • Cell Proliferation
  • Collagen Type IV (metabolism)
  • Down-Regulation
  • Extracellular Matrix (metabolism, pathology)
  • Gene Expression Regulation, Neoplastic
  • Glycoproteins (genetics, metabolism)
  • Humans
  • Integrin alpha1 (biosynthesis)
  • Laminin (metabolism)
  • Lung Neoplasms (genetics, pathology, physiopathology)
  • Male
  • Matrix Metalloproteinases (biosynthesis, genetics, metabolism)
  • Mice
  • Mice, Inbred BALB C
  • Mice, Nude
  • Neoplasm Invasiveness
  • Neoplasm Metastasis
  • Neoplasm Transplantation
  • RNA Interference
  • Signal Transduction
  • Stromal Cells
  • Transplantation, Heterologous
  • Tumor Microenvironment

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: